NBEA: Developmental disease gene with early generalized epilepsy phenotypes
- PMID: 30269351
- PMCID: PMC6249120
- DOI: 10.1002/ana.25350
NBEA: Developmental disease gene with early generalized epilepsy phenotypes
Abstract
NBEA is a candidate gene for autism, and de novo variants have been reported in neurodevelopmental disease (NDD) cohorts. However, NBEA has not been rigorously evaluated as a disease gene, and associated phenotypes have not been delineated. We identified 24 de novo NBEA variants in patients with NDD, establishing NBEA as an NDD gene. Most patients had epilepsy with onset in the first few years of life, often characterized by generalized seizure types, including myoclonic and atonic seizures. Our data show a broader phenotypic spectrum than previously described, including a myoclonic-astatic epilepsy-like phenotype in a subset of patients. Ann Neurol 2018;84:796-803.
© 2018 American Neurological Association.
Conflict of interest statement
Potential Conflicts of Interest
There are no potential conflicts of interest relevant to this manuscript.
Figures

References
-
- Barrett S, Beck JC, Bernier R, et al. An autosomal genomic screen for autism. Collaborative linkage study of autism. Am J Med Genet 1999;88:609–615. - PubMed
-
- Smith M, Woodroffe A, Smith R, et al. Molecular genetic delineation of a deletion of chromosome 13q12-->q13 in a patient with autism and auditory processing deficits. Cytogenet Genome Res 2002;98:233–239. - PubMed
-
- Steele MM, Al-Adeimi M, Siu VM, Fan YS. Brief report: A case of autism with interstitial deletion of chromosome 13. J Autism Dev Disord 2001;31:231–234. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases